Cadre (CDRE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Mar, 2026Executive summary
Achieved record annual adjusted EBITDA for the third consecutive year, driven by strong demand in public safety, defense, and nuclear markets, and successful execution of strategic objectives.
Completed acquisitions of Carr's Engineering and TYR Tactical, expanding capabilities, product offerings, and international reach.
Declared the 17th consecutive quarterly dividend, with an annualized increase to $0.40 per share.
Secured major contract wins in advanced sensor technologies and blast mitigation seating, increasing backlog and supporting future growth.
Maintained a strong balance sheet, enabling disciplined investments and ongoing M&A activity.
Financial highlights
FY 2025 net sales rose to $610.3 million from $567.6 million year-over-year; Q4 2025 net sales were $167.2 million, down from $176.0 million in Q4 2024.
FY 2025 net income was $44.1 million ($1.02 per diluted share), up from $36.1 million ($0.90) in FY 2024.
FY 2025 adjusted EBITDA reached $111.7 million (18.3% margin), a record for the third consecutive year.
FY 2025 gross margin improved by 140 basis points year-over-year to 43.9%.
Q4 results were down versus last year's record Q4 due to timing shifts and distribution softness.
Outlook and guidance
FY 2026 net sales guidance is $736–$758 million, with adjusted EBITDA expected between $136–$141 million (18.5% margin).
Organic growth for public safety and nuclear businesses expected at 3%-5%.
H2 2026 expected to be stronger, with Q1 revenue similar to Q3 2025 and margins around 39%.
Capital expenditures for 2026 projected at $10–$14 million, mainly for nuclear capacity expansion.
Latest events from Cadre
- Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation23 Mar 2026 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 20253 Feb 2026 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update1 Feb 2026 - Q2 net sales up 19% to $144.3M, adjusted EBITDA margin 19.6%, 2024 guidance unchanged post-cyber event.CDRE
Q2 20241 Feb 2026 - Stable demand, innovation, and operational focus drive growth and margin expansion.CDRE
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Cybersecurity incidents hit Q3, but record backlog and acquisitions support strong outlook.CDRE
Q3 202416 Jan 2026 - Strong market positions and strategic acquisitions drive growth in public safety and nuclear sectors.CDRE
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026 - Strong Q3 2025 results and strategic acquisitions drive growth in safety and nuclear markets.CDRE
Investor presentation14 Jan 2026 - £75M acquisition doubles global nuclear scale and expands safety, robotics, and medicine reach.CDRE
M&A Announcement10 Jan 2026